Iovance Biotherapeutics: Executives
Daniel KirbyChief Commercial OfficerFY2025
Frederick G. Vogt, Ph.D., J.D.Interim Chief Executive Officer and President, General CounselFY2025
Corleen RocheChief Financial OfficerFY2025
Raj K. Puri, M.D., Ph.D.Chief Regulatory OfficerFY2025
Igor Bilinsky, Ph.D.Chief Operating OfficerFY2025
Matthew W. RosinackInterim Principal Financial Officer and Principal Accounting OfficerFY2025
Jean-Marc BelleminFormer Chief Financial OfficerFY2025
7 executives

Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.